Suma M. Krishnan

2021

In 2021, Suma M. Krishnan earned a total compensation of $5.1M as President, R&D at Krystal Biotech, a 750% increase compared to previous year.

Compensation breakdown

Bonus$243,600
Option Awards$2,174,089
Salary$453,359
Stock Awards$2,240,473
Other$11,600
Total$5,123,121

Krishnan received $2.2M in stock awards, accounting for 44% of the total pay in 2021.

Krishnan also received $243.6K in bonus, $2.2M in option awards, $453.4K in salary and $11.6K in other compensation.

Rankings

In 2021, Suma M. Krishnan's compensation ranked 2,547th out of 12,397 executives tracked by ExecPay. In other words, Krishnan earned more than 79.5% of executives.

ClassificationRankingPercentile
All
2,547
out of 12,397
80th
Division
Manufacturing
1,012
out of 5,492
82nd
Major group
Chemicals And Allied Products
388
out of 2,367
84th
Industry group
Drugs
339
out of 2,090
84th
Industry
Biological Products, Except Diagnostic Substances
103
out of 452
77th
Source: SEC filing on April 7, 2022.

Krishnan's colleagues

We found three more compensation records of executives who worked with Suma M. Krishnan at Krystal Biotech in 2021.

2021

Andrew Orth

Krystal Biotech

Chief Commercial Officer

2021

Krish Krishnan

Krystal Biotech

Chief Executive Officer

2021

Kathryn Romano

Krystal Biotech

Chief Accounting Officer

News

You may also like